| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Departments of Surgical Oncology [B. K. Z., R. M. S., L. M. E.], Cancer Biology [S. Y., W. L., L. M. E.], and Thoracic Surgery [J. B. P.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, and Imclone Systems, Inc. [D. J. H.], New York, New York 10014
Vascular endothelial growth factor (VEGF) is an important mediator of angiogenesis and vascular permeability. We hypothesized that malignant pleural effusions may contain high levels of VEGF protein as well as other cytokines implicated in these processes. Pleural effusions cytologically proven to be malignant were collected from 39 patients with various types of cancer, and VEGF, interleukin-8, and angiogenin levels in the effusions were determined by immunoassay. Negative controls were nonmalignant ascites and serum samples from healthy individuals. VEGF levels were significantly higher than those of control samples in pleural effusions secondary to breast, mesothelioma, and non-small cell lung cancer and when all malignant pleural effusion samples were pooled. Neither interleukin-8 nor angiogenin levels were elevated in malignant pleural effusions relative to the control samples. Vascular permeability, which was measured by using the Miles assay in nude mice, was increased proportionately with VEGF levels in the malignant pleural effusions; this increase in permeability induced by injection of recombinant VEGF or the malignant effusions was reduced by pretreating the mice with a VEGF receptor antibody.
This article has been cited by other articles:
|
|
 |
|
  C. Nilsberth, L. Elander, N. Hamzic, M. Norell, J. Lonn, L. Engstrom, and A. Blomqvist The Role of Interleukin-6 in Lipopolysaccharide-Induced Fever by Mechanisms Independent of Prostaglandin E2 Endocrinology, April 1, 2009; 150(4): 1850 - 1860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhang, Y. Chen, H. Wei, C. Zheng, R. Sun, J. Zhang, and Z. Tian Antiapoptotic Activity of Autocrine Interleukin-22 and Therapeutic Effects of Interleukin-22-Small Interfering RNA on Human Lung Cancer Xenografts Clin. Cancer Res., October 15, 2008; 14(20): 6432 - 6439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T. Stathopoulos, C. Moschos, H. Loutrari, A. Kollintza, I. Psallidas, S. Karabela, S. Magkouta, Z. Zhou, S. A. Papiris, C. Roussos, et al. Zoledronic Acid Is Effective against Experimental Malignant Pleural Effusion Am. J. Respir. Crit. Care Med., July 1, 2008; 178(1): 50 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T. Stathopoulos, A. Kollintza, C. Moschos, I. Psallidas, T. P. Sherrill, E. N. Pitsinos, S. Vassiliou, M. Karatza, S. A. Papiris, D. Graf, et al. Tumor Necrosis Factor-{alpha} Promotes Malignant Pleural Effusion Cancer Res., October 15, 2007; 67(20): 9825 - 9834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gridelli, P. Maione, A. Rossi, and F. De Marinis The Role of Bevacizumab in the Treatment of Non-Small Cell Lung Cancer: Current Indications and Future Developments Oncologist, October 1, 2007; 12(10): 1183 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Tsao, D. He, B. Saigal, S. Liu, J. J. Lee, S. Bakkannagari, N. G. Ordonez, W. K. Hong, I. Wistuba, and F. M. Johnson Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion Mol. Cancer Ther., July 1, 2007; 6(7): 1962 - 1972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hossein Pourgholami, Z. Yan Cai, Y. Lu, L. Wang, and D. Lawson Morris Albendazole: a Potent Inhibitor of Vascular Endothelial Growth Factor and Malignant Ascites Formation in OVCAR-3 Tumor-Bearing Nude Mice. Clin. Cancer Res., March 15, 2006; 12(6): 1928 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Amino, Y. Ideyama, M. Yamano, S. Kuromitsu, K. Tajinda, K. Samizu, H. Hisamichi, A. Matsuhisa, K. Shirasuna, M. Kudoh, et al. YM-359445, an Orally Bioavailable Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor, Has Highly Potent Antitumor Activity against Established Tumors Clin. Cancer Res., March 1, 2006; 12(5): 1630 - 1638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Davidson, V. Espina, S. M. Steinberg, V. A. Florenes, L. A. Liotta, G. B. Kristensen, C. G. Trope, A. Berner, and E. C. Kohn Proteomic Analysis of Malignant Ovarian Cancer Effusions as a Tool for Biologic and Prognostic Profiling Clin. Cancer Res., February 1, 2006; 12(3): 791 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Demirag, E. Unsal, A. Yilmaz, and A. Caglar Prognostic Significance of Vascular Endothelial Growth Factor, Tumor Necrosis, and Mitotic Activity Index in Malignant Pleural Mesothelioma Chest, November 1, 2005; 128(5): 3382 - 3387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Hicklin and L. M. Ellis Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis J. Clin. Oncol., February 10, 2005; 23(5): 1011 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Wang, J. Teruya-Feldstein, Y. Wu, Z. Zhu, D. J. Hicklin, and M. A. S. Moore Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo Blood, November 1, 2004; 104(9): 2893 - 2902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sarkar, D. Chakroborty, R. B. Mitra, S. Banerjee, P. S. Dasgupta, and S. Basu Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, and focal adhesion kinase in endothelial cells Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1554 - H1560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamada, K. Sato, M. Komachi, E. Malchinkhuu, M. Tobo, T. Kimura, A. Kuwabara, Y. Yanagita, T. Ikeya, Y. Tanahashi, et al. Lysophosphatidic Acid (LPA) in Malignant Ascites Stimulates Motility of Human Pancreatic Cancer Cells through LPA1 J. Biol. Chem., February 20, 2004; 279(8): 6595 - 6605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S K Mohanty and P Dey Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review Postgrad. Med. J., October 1, 2003; 79(936): 569 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Stoeltzing, W. Liu, N. Reinmuth, A. Parikh, S. A. Ahmad, Y. D. Jung, F. Fan, and L. M. Ellis Angiogenesis and Antiangiogenic Therapy of Colon Cancer Liver Metastasis Ann. Surg. Oncol., August 1, 2003; 10(7): 722 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. van Hensbergen, H. J. Broxterman, R. Hanemaaijer, A. S. Jorna, N. A. van Lent, H. M. W. Verheul, H. M. Pinedo, and K. Hoekman Soluble Aminopeptidase N/CD13 in Malignant and Nonmalignant Effusions and Intratumoral Fluid Clin. Cancer Res., December 1, 2002; 8(12): 3747 - 3754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. F. Dvorak Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy J. Clin. Oncol., November 1, 2002; 20(21): 4368 - 4380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Hata, K. Tanaka, T. Imaizumi, T. Ohara, T. Ohba, T. Shinada, and T. Takano Clinical Significance of Pleural Effusion in Acute Aortic Dissection Chest, March 1, 2002; 121(3): 825 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. ROMANO, A. CATALANO, M. NUTINI, E. D'URBANO, C. CRESCENZI, J. CLARIA, R. LIBNER, G. DAVI, and A. PROCOPIO 5-Lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor FASEB J, November 1, 2001; 15(13): 2326 - 2336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Catalano, M. Romano, I. Robuffo, L. Strizzi, and A. Procopio Methionine Aminopeptidase-2 Regulates Human Mesothelioma Cell Survival : Role of Bcl-2 Expression and Telomerase Activity Am. J. Pathol., August 1, 2001; 159(2): 721 - 731. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. J. Metheny-Barlow, B. Flynn, H. E. van Gijssel, A. Marrogi, and B. I. Gerwin Paradoxical Effects of Platelet-Derived Growth Factor-A Overexpression in Malignant Mesothelioma . Antiproliferative Effects In Vitro and Tumorigenic Stimulation In Vivo Am. J. Respir. Cell Mol. Biol., June 1, 2001; 24(6): 694 - 702. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
